Prescription drug · ANDA
Warfarin Sodium (Warfarin) NDC 71610-448
Warfarin sodium 5 mg/1 · Tablet · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-448-11 | 7161004481171610044811 | 48 TABLET in 1 BOTTLE (71610-448-11)Marketed from Jul 30, 2020 | |
| 71610-448-15 | 7161004481571610044815 | 15 TABLET in 1 BOTTLE (71610-448-15)Marketed from Jul 30, 2020 | |
| 71610-448-20 | 7161004482071610044820 | 20 TABLET in 1 BOTTLE (71610-448-20)Marketed from Jul 30, 2020 | |
| 71610-448-21 | 7161004482171610044821 | 32 TABLET in 1 BOTTLE (71610-448-21)Marketed from Jul 30, 2020 | |
| 71610-448-25 | 7161004482571610044825 | 25 TABLET in 1 BOTTLE (71610-448-25)Marketed from Jul 30, 2020 | |
| 71610-448-28 | 7161004482871610044828 | 28 TABLET in 1 BOTTLE (71610-448-28)Marketed from Jul 30, 2020 | |
| 71610-448-30 | 7161004483071610044830 | 30 TABLET in 1 BOTTLE (71610-448-30)Marketed from Jul 30, 2020 | |
| 71610-448-35 | 7161004483571610044835 | 35 TABLET in 1 BOTTLE (71610-448-35)Marketed from Jul 30, 2020 | |
| 71610-448-38 | 7161004483871610044838 | 55 TABLET in 1 BOTTLE (71610-448-38)Marketed from Jul 30, 2020 | |
| 71610-448-40 | 7161004484071610044840 | 40 TABLET in 1 BOTTLE (71610-448-40)Marketed from Jul 30, 2020 | |
| 71610-448-44 | 7161004484471610044844 | 36 TABLET in 1 BOTTLE (71610-448-44)Marketed from Jul 30, 2020 | |
| 71610-448-45 | 7161004484571610044845 | 45 TABLET in 1 BOTTLE (71610-448-45)Marketed from Jul 30, 2020 | |
| 71610-448-46 | 7161004484671610044846 | 56 TABLET in 1 BOTTLE (71610-448-46)Marketed from Jul 30, 2020 | |
| 71610-448-47 | 7161004484771610044847 | 24 TABLET in 1 BOTTLE (71610-448-47)Marketed from Jul 30, 2020 | |
| 71610-448-50 | 7161004485071610044850 | 50 TABLET in 1 BOTTLE (71610-448-50)Marketed from Jul 30, 2020 | |
| 71610-448-53 | 7161004485371610044853 | 60 TABLET in 1 BOTTLE (71610-448-53)Marketed from Jul 30, 2020 | |
| 71610-448-55 | 7161004485571610044855 | 75 TABLET in 1 BOTTLE (71610-448-55)Marketed from Jul 30, 2020 | |
| 71610-448-59 | 7161004485971610044859 | 22 TABLET in 1 BOTTLE (71610-448-59)Marketed from Jul 30, 2020 | |
| 71610-448-60 | 7161004486071610044860 | 90 TABLET in 1 BOTTLE (71610-448-60)Marketed from Jul 30, 2020 | |
| 71610-448-61 | 7161004486171610044861 | 70 TABLET in 1 BOTTLE (71610-448-61)Marketed from Jul 30, 2020 | |
| 71610-448-68 | 7161004486871610044868 | 26 TABLET in 1 BOTTLE (71610-448-68)Marketed from Jul 30, 2020 | |
| 71610-448-78 | 7161004487871610044878 | 34 TABLET in 1 BOTTLE (71610-448-78)Marketed from Jul 30, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Warfarin Sodium
- Generic name (nonproprietary)
- warfarin
- Active ingredients
- Warfarin sodium — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090935
- Marketing start
- Listing expires
- Other FDA classes
- Vitamin K Inhibitors (Mechanism)
- Identifiers
- Product ID 71610-448_c6ed46d9-0050-4c67-9a18-378ab6bf3ab3SPL ID c6ed46d9-0050-4c67-9a18-378ab6bf3ab3SPL set ID 91f24482-d4cb-4a09-a97e-64f6e49071eeRxCUI 855332UNII 6153CWM0CL
- Pharmacologic class
- Vitamin K Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610044811followed by a unit qualifier and the quantityPackage 71610-0448-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
1. INDICATIONS AND USAGE Warfarin sodium tablets, are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. Limitations of Use Warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. Once a thrombus has occurred, however, the goals of anticoagulant treatment are to prevent further extens…
Excerpt only. Read the full label for complete information.
About NDC 71610-448
- What is NDC 71610-448?
- 71610-448 is the product NDC for Warfarin Sodium (warfarin), Warfarin sodium 5 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 22 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Warfarin Sodium (Warfarin).
- What is the active ingredient?
- Warfarin sodium.
- Who is the labeler?
- Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Warfarin Sodium?
- 138 other product NDCs are listed under this name. See all Warfarin Sodium NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Warfarin Sodium products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Warfarin Sodiumwarfarin | Warfarin sodium 2.5 mg/1 | TabletOral | Coupler LLC | 67046-1145 | 67046-1145-03 |
| Warfarin Sodiumwarfarin | Warfarin sodium 3 mg/1 | TabletOral | Coupler LLC | 67046-1185 | 67046-1185-03 |
| Warfarin Sodium | Warfarin sodium 3 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4722 | 70518-4722-00 |
| Warfarin Sodiumwarfarin | Warfarin sodium 10 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4684 | 70518-4684-00 |
| Warfarin Sodiumwarfarin | Warfarin sodium 1 mg/1 | TabletOral | Coupler LLC | 67046-2072 | 67046-2072-03 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2 mg/1 | TabletOral | Coupler LLC | 67046-1067 | 67046-1067-03 |
| Warfarin Sodium | Warfarin sodium 2.5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4634 | 70518-4634-00 |
| Warfarin Sodium | Warfarin sodium 7.5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4635 | 70518-4635-00 |
| Warfarin Sodium | Warfarin sodium 10 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4636 | 70518-4636-00 |
| Warfarin Sodium | Warfarin sodium 1 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4637 | 70518-4637-00 |
Other NDCs under ANDA 090935
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Warfarin Sodiumwarfarin | Warfarin sodium 2 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-021 |
| Warfarin Sodiumwarfarin | Warfarin sodium 5 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-023 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2.5 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-029 |
| Warfarin Sodiumwarfarin | Warfarin sodium 3 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-030 |
| Warfarin Sodiumwarfarin | Warfarin sodium 4 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-033 |
| Warfarin Sodiumwarfarin | Warfarin sodium 7.5 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-053 |
| Warfarin Sodiumwarfarin | Warfarin sodium 10 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-054 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-342 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2.5 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-343 |
| Warfarin Sodiumwarfarin | Warfarin sodium 3 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-344 |
| Warfarin Sodiumwarfarin | Warfarin sodium 4 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-345 |
| Warfarin Sodiumwarfarin | Warfarin sodium 5 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-346 |
| Warfarin Sodiumwarfarin | Warfarin sodium 6 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-347 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-462 |
| Warfarin Sodiumwarfarin | Warfarin sodium 4 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-490 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2.5 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-491 |
| Warfarin Sodium | Warfarin sodium 10 mg/1 | TabletOral | DIRECT RX | 72189-210 |
| Warfarin Sodiumwarfarin | Warfarin sodium 1 mg/1 | TabletOral | Exelan Pharmaceuticals Inc. | 76282-327 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2 mg/1 | TabletOral | Exelan Pharmaceuticals Inc. | 76282-328 |
| Warfarin Sodiumwarfarin | Warfarin sodium 2.5 mg/1 | TabletOral | Exelan Pharmaceuticals Inc. | 76282-329 |
Showing 20 of 26.